Chartwell Investment Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,086	Closed	-$691K	–	426
2022 Q2	$691K	Buy	7,086 +106	+2%	+$9.78K	0.03%	379
2022 Q1	$654K	Buy	6,980 +408	+6%	+$34.6K	0.02%	396
2021 Q4	$560K	Hold	6,572	–	–	0.02%	406
2021 Q3	$630K	Sell	6,572 -15,271	-70%	-$1.44M	0.02%	403
2021 Q2	$2.13M	Sell	21,843 -14	-0.1%	-$1.34K	0.06%	287
2021 Q1	$2.13M	Sell	21,857 -2,175	-9%	-$228K	0.06%	276
2020 Q4	$2.3M	Buy	24,032 +214	+0.9%	+$20.7K	0.07%	266
2020 Q3	$2.29M	Buy	23,818 +4,918	+26%	+$569K	0.08%	255
2020 Q2	$2.31M	Buy	18,900 +12,782	+209%	+$1.41M	0.09%	254
2020 Q1	$530K	Sell	6,118 -300	-5%	-$29.4K	0.02%	364
2019 Q4	$690K	Hold	6,418	–	–	0.02%	374
2019 Q3	$578K	Sell	6,418 -182	-3%	-$17K	0.02%	386
2019 Q2	$557K	Sell	6,600 -1,507	-19%	-$124K	0.02%	394
2019 Q1	$714K	Buy	8,107 +413	+5%	+$34.5K	0.02%	400
2018 Q4	$549K	Sell	7,694 -362	-4%	-$34.7K	0.02%	424
2018 Q3	$990K	Sell	8,056 -33,122	-80%	-$3.76M	0.03%	442
2018 Q2	$4.04M	Sell	41,178 -20,081	-33%	-$1.8M	0.12%	230
2018 Q1	$5.08M	Sell	61,259 -1,023	-2%	-$86.4K	0.17%	184
2017 Q4	$4.83M	Sell	62,282 -11,146	-15%	-$760K	0.16%	203
2017 Q3	$4.5M	Buy	73,428 +3,532	+5%	+$186K	0.15%	204
2017 Q2	$3.21M	Buy	69,896 +3,992	+6%	+$194K	0.12%	231
2017 Q1	$2.85M	Sell	65,904 -80,108	-55%	-$3.43M	0.1%	240
2016 Q4	$5.65M	Buy	146,012 +24,057	+20%	+$1.09M	0.19%	170
2016 Q3	$6.18M	Buy	+121,955	New	+$6.07M	0.11%	225